Skip to content
etf.net

UYG vs XBIX

ProShares Ultra Financials

UYGANYSE Arca

Corgi U.S. Biotech 2x Daily ETF

XBIXCCboe

Overlap

Expense ratio

XBIX −0.48pt a year

UYG0.93%XBIX0.45%

Avg volume · 30D

UYG 10.8×the volume

UYG17.3KXBIX1.6K

UYG vs XBIX Performance

Jul 31, 2026 – Oct 30, 2026

−2.7%UYG+6.5%XBIX

Jul 31, 2026 to Oct 30, 2026. UYG −2.7%. XBIX +6.5%. Use the arrow keys to read each point.−10%20%30%Jul 2026Sep 2026Oct 2026
Expense ratio
UYG 0.93%
XBIX 0.45%, better
Fund size
UYG $777M
XBIX $0
1Y total return
UYG +11.5%
XBIX No data
Yield (12M)
UYG 11.13%
XBIX No data
Holdings
UYG 83
XBIX 1
Avg volume (30D)
UYG 17.3K sh, better
XBIX 1.6K sh
NAV per share
UYG $93.27
XBIX $34.24
52W range

ETF.net Grade

UYG: Cost 70, Risk 76, Mission not scored, Tradability 78, Holdings not scored, Durability 80. XBIX: Cost 86, Risk 62, Mission not scored, Tradability 28, Holdings not scored, Durability 20.
Pillar letters and Scores for UYG, XBIX, with each pillar’s weight
PillarUYGXBIX
Cost30% weightA70A86Higher
Mission25% weightNot scoredNot scored
Risk15% weightA76HigherB62
Tradability15% weightA78HigherD28
Holdings10% weightNot scoredNot scored
Durability5% weightA80HigherF20

Rank among Leveraged Long (2x & Other) funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. UYG and XBIX are both graded against the same 95 Leveraged Long (2x & Other) funds, so their Grades compare head to head.

Leveraged Long (2x & Other)⁠

Category · 95 funds
See all 95 ›

UYG ranks 2nd and XBIX 37th of 95 funds in the Leveraged Long (2x & Other) Category.

  1. Rank 1AQLDProShares Ultra QQQScore 77
  2. Rank 2AUYGProShares Ultra FinancialsScore 74
  3. Rank 3AROMProShares Ultra TechnologyScore 71
  4. Rank 37CWXCorgi All World 2x Daily ETFScore 40
  5. Rank 37CXBIXCorgi U.S. Biotech 2x Daily ETFScore 40
  6. Rank 37CXCOMCorgi All Commodities 2x Daily ETFScore 40

Our read on each fund

ETF.net Research

UYGAProShares Ultra Financials

XBIXCCorgi U.S. Biotech 2x Daily ETF

In short

UYG Listed in January 2007, a year before the banking crash, UYG targets 2x the daily move of the financial stocks in the S&P 500. A veteran of the leveraged shelf, priced at 0.93% with no fee waiver propping that number up.

XBIX No data

Stated mandate

UYG UYG seeks pre-expense daily results equal to 2x the daily performance of the S&P Financial Select Sector Index. It is designed to provide magnified financials-sector exposure on a daily basis.

XBIX No data

Why people hold it

  • UYG One of the originals: on the tape since January 30, 2007, still running the same mandate of 2x the daily performance of the S&P Financial Select Sector Index.proshares.com
  • At 0.93% with no waiver doing the work, it sits near the median fee of its leveraged peer group and level with sibling ROM (0.93%). QLD is 0.89%, but net of a waiver through September 30, 2027.
  • The whole sector in one ticker: banks, insurers and capital-markets firms from the S&P 500, roughly 80 names, geared daily.proshares.com
  • Stands in the top tier of the leveraged bull funds we grade, a group of close to a hundred tickers.

XBIX No data

Worth knowing

  • UYG The 2x target is a one-day target and resets each day. Over longer holds the result comes from compounding daily moves, and in choppy markets that can land well off twice the index's return for the period.proshares.com
  • One sector, doubled. Financials move with rates, credit conditions and deal flow, and UYG amplifies that daily swing in both directions.
  • It changes hands less than the headline leveraged funds, so the spread is worth a look before you place an order.

XBIX No data

Full UYG profile⁠

Full XBIX profile⁠

UYG vs XBIX Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

UYG vs XBIX Cost

Overpaying UYG vs XBIX

$8,498

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • UYG 0.93%

    $17,539

  • XBIX 0.45%

    $9,041

$10,000
30 years

Cost over time

  • UYG 0.93%
  • XBIX 0.45%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530UYG $17,539XBIX $9,041

Year by year

YearUYGXBIXOverpaying
10$1,644$812$832
20$6,199$3,128$3,071
30$17,539$9,041$8,498

Expense ratio

  • 0.93%UYG
  • 0.45%XBIX, cheaper
  • Middle half of Leveraged Long (2x & Other) funds
  • Median 0.95%

XBIX 3rd cheapest of 95 funds

UYG 29th cheapest of 95 funds

UYG vs XBIX Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
UYG 11.13%
XBIX No data
Payout (12M)
UYG $10.38
XBIX None
Last payment
UYG $0.09
XBIX No data
Ex-dividend
UYG Sep 23, 2026
XBIX No data
Paid on
UYG Sep 29, 2026
XBIX No data
Frequency
UYG Quarterly
XBIX No data

Distribution history

Per share, 2017 to 2026, same scale for both

UYGQuarterly · 39 paymentsAll UYG payments⁠
One bar per payment. 39 payments from 2017 to 2026 YTD. Mar 22, 2017 $0.02; Jun 21, 2017 $0.02; Sep 27, 2017 $0.07; Dec 26, 2017 $0.12; Mar 21, 2018 $0.05; Jun 20, 2018 $0.08; Sep 26, 2018 $0.11; Dec 26, 2018 $0.18; Mar 20, 2019 $0.08; Jun 25, 2019 $0.09; Sep 25, 2019 $0.14; Dec 24, 2019 $0.17; Mar 25, 2020 $0.12; Jun 24, 2020 $0.05; Sep 23, 2020 $0.03; Dec 23, 2020 $0.08; Mar 23, 2021 $0.03; Jun 22, 2021 $0.02; Sep 22, 2021 $0.03; Dec 23, 2021 $3.19; Mar 23, 2022 $0.04; Jun 22, 2022 $0.04; Sep 21, 2022 $0.06; Dec 22, 2022 $0.20; Mar 22, 2023 $0.09; Jun 21, 2023 $0.11; Sep 20, 2023 $0.09; Dec 20, 2023 $0.15; Mar 20, 2024 $0.04; Jun 26, 2024 $0.11; Sep 25, 2024 $0.09; Dec 23, 2024 $0.20; Mar 26, 2025 $0.27; Jun 25, 2025 $0.13; Sep 24, 2025 $0.38; Dec 24, 2025 $9.97; Mar 25, 2026 $0.20; Jun 24, 2026 $0.11; Sep 23, 2026 $0.09. Use the arrow keys to read each point.$0$102017202020232026YTD
XBIXAll XBIX payments⁠

No distribution history available.

UYG vs XBIX Risk

Fall from peak · 5 years

This chart needs five years of history for both funds.

Risk facts

VolatilityStd dev, 3 years
UYG 30.5%XBIX No data
Return per unit of riskSharpe ratio, 3 years
UYG 1.04XBIX No data
Worst fallMax drawdown, 5 years
UYG −47.8%XBIX No data
Market sensitivityBeta, 5 years
UYG 1.58XBIX 0.00

Popular comparisons

  • UYGAvsQLDA

    ProShares Ultra Financials · ProShares Ultra QQQ

    Expense ratio
    0.93% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • XBIXCvsQLDA

    Corgi U.S. Biotech 2x Daily ETF · ProShares Ultra QQQ

    Expense ratio
    0.45% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • UYGAvsROMA

    ProShares Ultra Financials · ProShares Ultra Technology

    Expense ratio
    0.93% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • XBIXCvsROMA

    Corgi U.S. Biotech 2x Daily ETF · ProShares Ultra Technology

    Expense ratio
    0.45% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • UYGAvsDDMB

    ProShares Ultra Financials · ProShares Ultra Dow30

    Expense ratio
    0.93% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • XBIXCvsDDMB

    Corgi U.S. Biotech 2x Daily ETF · ProShares Ultra Dow30

    Expense ratio
    0.45% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.